期刊
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
卷 59, 期 8, 页码 3226-3234出版社
WILEY-V C H VERLAG GMBH
DOI: 10.1002/anie.201912122
关键词
antimicrobial immunity; drug delivery; phagolysosomal destruction; selenium nanoparticles; tuberculosis
资金
- NIH [RO1HL129887, RO1OD15092, RO1HL64560]
- National Natural Science Foundation of China for Young Scientists [81801649]
- Fundamental Research Funds for the Central Universities [19ykpy161]
- Guangzhou Science and Technology Project [201904010273, 201904010455]
- China Postdoctoral Science Foundation [2018M631026]
- Shanghai Key Laboratory of Tuberculosis (lung) Grant [2018kf04]
- Guangdong Natural Science Foundation Grant [2018A030313118, 2015A030306028]
- Guangdong Science and Technology Project Grant [2018A050506032]
- National Key RD Plan Grant [2016YFE0106900]
- NSFC [81622029, 31670879, 81361120379]
Pathogenesis hallmarks for tuberculosis (TB) are the Mycobacterium tuberculosis (Mtb) escape from phagolysosomal destruction and limited drug delivery into infected cells. Several nanomaterials can be entrapped in lysosomes, but the development of functional nanomaterials to promote phagolysosomal Mtb clearance remains a big challenge. Here, we report on the bactericidal effects of selenium nanoparticles (Se NPs) against Mtb and further introduce a novel nanomaterial-assisted anti-TB strategy manipulating Ison@Man-Se NPs for synergistic drug-induced and phagolysosomal destruction of Mtb. Ison@Man-Se NPs preferentially entered macrophages and accumulated in lysosomes releasing Isoniazid. Surprisingly, Ison@Man-Se/Man-Se NPs further promoted the fusion of Mtb into lysosomes for synergistic lysosomal and Isoniazid destruction of Mtb. Concurrently, Ison@Man-Se/Man-Se NPs also induced autophagy sequestration of Mtb, evolving into lysosome-associated autophagosomal Mtb degradation linked to ROS-mitochondrial and PI3K/Akt/mTOR signaling pathways. This novel nanomaterial-assisted anti-TB strategy manipulating antimicrobial immunity and Mtb clearance may potentially serve in more effective therapeutics against TB and drug-resistant TB.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据